
Sandostatin 0.05mg Injection
Marketer
Novartis India Ltd
Salt Composition
Octreotide acetate (0.05mg)
Overview Sandostatin 0.05mg Injection
Octreotide acetate 0.05mg injection treats acromegaly, carcinoid tumors, and gastrointestinal bleeding from esophageal varices. It also helps prevent post-pancreatic surgery complications. Administration is exclusively by a medical professional; self-injection is strictly prohibited. Dosage and frequency are determined solely by your physician. Consistent use is crucial for optimal therapeutic effect; discontinuation should only occur under medical supervision. Common side effects include nausea, diarrhea, abdominal pain, constipation, flatulence, and headache. Report persistent or worsening side effects to your doctor. Prior to treatment, disclose any liver conditions and a complete list of all medications you are currently using.
Primary Ingredients of Sandostatin 0.05mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Sandostatin 0.05mg Injection
Overgrowth disorders|Neuroendocrine neoplasms|Hemorrhaging esophageal varices
Major Benefits of Sandostatin 0.05mg Injection:
Administering this medication will be done by your doctor or nurse; self-medication is strictly prohibited.
Common Side effects of Sandostatin 0.05mg Injection:
- Diarrhea
- Abdominal pain
- Nausea
- Constipation
- Flatulence
- Headache
- Increased glucose level in blood
- Injection site reaction
How to use Sandostatin 0.05mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Sandostatin 0.05mg Injection works:
Octreotide acetate 0.05mg injection mimics the action of somatostatin, a naturally occurring hormone in humans that suppresses the release of various hormones, including growth hormone. This medication also reduces esophageal bleeding by causing vasoconstriction.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Sandostatin 0.05mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
Octreotide acetate 0.05mg injection is typically deemed safe for use in pregnancy. Preclinical trials in animals have revealed minimal or absent harm to the fetus; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Octreotide 0.05mg injection is likely compatible with breastfeeding. Available human data indicates minimal infant risk associated with its use.
DrivingSAFE
Driving ability is typically unaffected by Sandostatin 0.05mg Injection.
KidneySAFE IF PRESCRIBED
Octreotide acetate 0.05mg injection poses no known safety concerns for patients with renal impairment. No alteration of the octreotide acetate 0.05mg injection dosage is necessary in such cases.
LiverCAUTION
Octreotide acetate 0.05mg injection requires careful administration in individuals with hepatic impairment. Dosage modification for octreotide acetate 0.05mg injection might be necessary. Physician consultation is advised.
What if you forget to take Sandostatin 0.05mg Injection :
Should you forget a Sandostatin 0.05mg Injection, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Sandostatin 0.05mg Injection
| Label | Value |
|---|---|
| Chemical Classification | Somatostatin analogs |
| Developing Habits | No. |
| Type of Therapy | Endocrine Signals |
| Actions | Somatostatin analogs |
